• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态对比增强磁共振成像和动态磁敏感对比磁共振成像在脑胶质瘤研究中的可重复性:使用不同商业软件获得的数据比较

Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.

作者信息

Conte Gian Marco, Castellano Antonella, Altabella Luisa, Iadanza Antonella, Cadioli Marcello, Falini Andrea, Anzalone Nicoletta

机构信息

Neuroradiology Unit and CERMAC, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, via Olgettina 60, 20132, Milan, Mi, Italy.

Department of Medical Physics, San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Mi, Italy.

出版信息

Radiol Med. 2017 Apr;122(4):294-302. doi: 10.1007/s11547-016-0720-8. Epub 2017 Jan 9.

DOI:10.1007/s11547-016-0720-8
PMID:28070841
Abstract

PURPOSE

Dynamic susceptibility contrast MRI (DSC) and dynamic contrast-enhanced MRI (DCE) are useful tools in the diagnosis and follow-up of brain gliomas; nevertheless, both techniques leave the open issue of data reproducibility. We evaluated the reproducibility of data obtained using two different commercial software for perfusion maps calculation and analysis, as one of the potential sources of variability can be the software itself.

METHODS

DSC and DCE analyses from 20 patients with gliomas were tested for both the intrasoftware (as intraobserver and interobserver reproducibility) and the intersoftware reproducibility, as well as the impact of different postprocessing choices [vascular input function (VIF) selection and deconvolution algorithms] on the quantification of perfusion biomarkers plasma volume (Vp), volume transfer constant (K ) and rCBV. Data reproducibility was evaluated with the intraclass correlation coefficient (ICC) and Bland-Altman analysis.

RESULTS

For all the biomarkers, the intra- and interobserver reproducibility resulted in almost perfect agreement in each software, whereas for the intersoftware reproducibility the value ranged from 0.311 to 0.577, suggesting fair to moderate agreement; Bland-Altman analysis showed high dispersion of data, thus confirming these findings. Comparisons of different VIF estimation methods for DCE biomarkers resulted in ICC of 0.636 for K and 0.662 for Vp; comparison of two deconvolution algorithms in DSC resulted in an ICC of 0.999.

CONCLUSIONS

The use of single software ensures very good intraobserver and interobservers reproducibility. Caution should be taken when comparing data obtained using different software or different postprocessing within the same software, as reproducibility is not guaranteed anymore.

摘要

目的

动态磁敏感对比增强磁共振成像(DSC)和动态对比增强磁共振成像(DCE)是脑胶质瘤诊断和随访中的有用工具;然而,这两种技术都存在数据可重复性的问题。我们评估了使用两种不同商业软件进行灌注图计算和分析所获得数据的可重复性,因为软件本身可能是变异性的潜在来源之一。

方法

对20例胶质瘤患者的DSC和DCE分析进行了软件内(作为观察者内和观察者间可重复性)和软件间可重复性测试,以及不同后处理选择[血管输入函数(VIF)选择和去卷积算法]对灌注生物标志物血浆容积(Vp)、容积转移常数(K)和相对脑血容量(rCBV)定量的影响。使用组内相关系数(ICC)和布兰德-奥特曼分析评估数据可重复性。

结果

对于所有生物标志物,观察者内和观察者间的可重复性在每个软件中几乎完全一致,而软件间可重复性的值范围为0.311至0.577,表明一致性为中等;布兰德-奥特曼分析显示数据分散性高,从而证实了这些发现。DCE生物标志物不同VIF估计方法的比较得出K的ICC为0.636,Vp的ICC为0.662;DSC中两种去卷积算法的比较得出ICC为0.999。

结论

使用单一软件可确保非常好的观察者内和观察者间可重复性。在比较使用不同软件或同一软件内不同后处理获得的数据时应谨慎,因为不再保证可重复性。

相似文献

1
Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.动态对比增强磁共振成像和动态磁敏感对比磁共振成像在脑胶质瘤研究中的可重复性:使用不同商业软件获得的数据比较
Radiol Med. 2017 Apr;122(4):294-302. doi: 10.1007/s11547-016-0720-8. Epub 2017 Jan 9.
2
Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.动态对比增强和动态磁敏感对比灌注磁共振成像用于胶质瘤分级:使用热点和直方图分析对血管腔室和通透性参数的初步比较
Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22.
3
Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.脑胶质瘤:动态对比增强和动态磁敏感对比磁共振成像的多中心标准化评估。
Radiology. 2018 Jun;287(3):933-943. doi: 10.1148/radiol.2017170362. Epub 2018 Jan 22.
4
Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.基于模型和模型自由的动态对比增强 MRI 纹理特征参数图在胶质瘤分级中的应用。
J Magn Reson Imaging. 2018 Apr;47(4):1099-1111. doi: 10.1002/jmri.25835. Epub 2017 Aug 28.
5
Dynamic Contrast-Enhanced Perfusion MRI of High Grade Brain Gliomas Obtained with Arterial or Venous Waveform Input Function.采用动脉或静脉波形输入函数获得的高级别脑胶质瘤动态对比增强灌注磁共振成像
J Neuroimaging. 2016 Jan-Feb;26(1):124-9. doi: 10.1111/jon.12254. Epub 2015 Apr 29.
6
Correlation Between Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters in Rectal Cancer.直肠癌体素内不相干运动与动态对比增强磁共振成像参数的相关性。
Acad Radiol. 2019 Jul;26(7):e134-e140. doi: 10.1016/j.acra.2018.08.012. Epub 2018 Sep 27.
7
Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.动态对比增强磁共振成像:使用模拟数据和临床数据研究软件间的准确性和可重复性。
J Magn Reson Imaging. 2016 Jun;43(6):1288-300. doi: 10.1002/jmri.25101. Epub 2015 Dec 21.
8
T2*-correction in dynamic contrast-enhanced MRI from double-echo acquisitions.基于双回波采集的动态对比增强磁共振成像中的T2*校正
J Magn Reson Imaging. 2014 May;39(5):1314-9. doi: 10.1002/jmri.24268. Epub 2013 Oct 10.
9
Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.肾细胞癌的动态对比增强磁共振成像测量:感兴趣区大小和定位对观察者间及观察者内变异性的影响。
Invest Radiol. 2015 Jan;50(1):57-66. doi: 10.1097/RLI.0000000000000096.
10
Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.胶质瘤患者肿瘤免疫组织化学与动态对比增强及DSC-MRI参数的相关性
AJNR Am J Neuroradiol. 2016 Dec;37(12):2217-2223. doi: 10.3174/ajnr.A4908. Epub 2016 Sep 1.

引用本文的文献

1
Understanding Permeability Changes in Vestibular Schwannomas as Part of the Dynamic Response to Radiosurgery Using Golden-Angle Radial Sparse Parallel Imaging: A Retrospective Study.利用黄金角径向稀疏并行成像理解前庭神经鞘瘤的渗透性变化作为对放射外科动态反应的一部分:一项回顾性研究。
Neurosurgery. 2024 Dec 3;97(1):157-165. doi: 10.1227/neu.0000000000003288.
2
Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.结构和扩散张量成像磁共振成像能够自动预测中枢神经系统WHO 2-4级胶质瘤患者的异柠檬酸脱氢酶(IDH)突变状态:一种深度放射组学方法。
BMC Med Imaging. 2024 May 3;24(1):104. doi: 10.1186/s12880-024-01274-9.
3

本文引用的文献

1
Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.胶质母细胞瘤患者标准治疗后非强化T2高信号病变的预后预测:动态对比增强磁共振成像的应用
Eur Radiol. 2017 Mar;27(3):1176-1185. doi: 10.1007/s00330-016-4464-6. Epub 2016 Jun 29.
2
Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation.通过MGMT启动子甲基化分层的胶质母细胞瘤亚组中,成像参数对预测假性进展的不同诊断价值。
Eur Radiol. 2017 Jan;27(1):255-266. doi: 10.1007/s00330-016-4346-y. Epub 2016 Apr 5.
3
Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions.
用于鉴别胶质瘤与治疗效果的先进磁共振成像方案:现状与未来方向
Front Radiol. 2022 Apr 15;2:809373. doi: 10.3389/fradi.2022.809373. eCollection 2022.
4
A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors.多阅读者比较正常表现的脑肿瘤灌注和弥散 MRI 的白质归一化技术。
Neuroradiology. 2023 Mar;65(3):559-568. doi: 10.1007/s00234-022-03072-y. Epub 2022 Oct 27.
5
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.通过PET和MRI解码恶性胶质瘤的异质性以进行缺氧、灌注和扩散成像的空间栖息地分析:一项初步研究
Front Neurosci. 2022 Jul 13;16:885291. doi: 10.3389/fnins.2022.885291. eCollection 2022.
6
Volumetric Measurement of Relative CBV Using T1-Perfusion-Weighted MRI with High Temporal Resolution Compared with Traditional T2*-Perfusion-Weighted MRI in Postoperative Patients with High-Grade Gliomas.利用高时间分辨率 T1 灌注加权 MRI 对高级别脑胶质瘤术后患者进行相对 CBV 容积测量,与传统 T2*-灌注加权 MRI 比较。
AJNR Am J Neuroradiol. 2022 Jun;43(6):864-871. doi: 10.3174/ajnr.A7527. Epub 2022 May 26.
7
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques.高级别胶质瘤治疗反应监测生物标志物:关于支持在临床中使用先进MRI技术的证据以及最新的从 bench 到 bedside 进展的立场声明。第1部分:灌注和扩散技术。
Front Oncol. 2022 Mar 3;12:810263. doi: 10.3389/fonc.2022.810263. eCollection 2022.
8
Reproducibility of dynamic contrast enhanced MRI derived transfer coefficient Ktrans in lung cancer.动态对比增强 MRI 衍生的转移系数 Ktrans 在肺癌中的可重复性。
PLoS One. 2022 Mar 8;17(3):e0265056. doi: 10.1371/journal.pone.0265056. eCollection 2022.
9
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper.二十年回顾:实体瘤疗效评估标准(RECIST)作为实体瘤反应生物标志物——欧洲癌症研究与治疗组织(EORTC)影像组与欧洲肿瘤内科学会(ESOI)联合论文
Front Oncol. 2022 Jan 10;11:800547. doi: 10.3389/fonc.2021.800547. eCollection 2021.
10
Multicenter DSC-MRI-Based Radiomics Predict IDH Mutation in Gliomas.基于多中心扩散加权磁共振成像的影像组学预测胶质瘤中的异柠檬酸脱氢酶突变
Cancers (Basel). 2021 Aug 5;13(16):3965. doi: 10.3390/cancers13163965.
Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.
从灌注磁共振成像中鉴定一种候选生物标志物,以预测胶质母细胞瘤放化疗后的进展。
Eur Radiol. 2016 Nov;26(11):4194-4203. doi: 10.1007/s00330-016-4234-5. Epub 2016 Feb 2.
4
Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.高级别和低级别胶质瘤与转移瘤的最佳鉴别:灌注、扩散及波谱学指标的荟萃分析
Neuroradiology. 2016 Apr;58(4):339-50. doi: 10.1007/s00234-016-1642-9. Epub 2016 Jan 15.
5
Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.动态对比增强磁共振成像:使用模拟数据和临床数据研究软件间的准确性和可重复性。
J Magn Reson Imaging. 2016 Jun;43(6):1288-300. doi: 10.1002/jmri.25101. Epub 2015 Dec 21.
6
Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.利用扩散张量成像和动态磁敏感对比磁共振成像鉴别胶质母细胞瘤患者的肿瘤进展与假性进展
AJNR Am J Neuroradiol. 2016 Jan;37(1):28-36. doi: 10.3174/ajnr.A4474. Epub 2015 Oct 8.
7
Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.用于评估胶质母细胞瘤治疗反应和预后的生理磁共振成像
Neuro Oncol. 2016 Apr;18(4):467-78. doi: 10.1093/neuonc/nov179. Epub 2015 Sep 12.
8
Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas.基于动态对比增强磁共振成像的早期生物标志物预测高级别胶质瘤抗血管生成治疗反应
Neuroradiology. 2015 Dec;57(12):1269-80. doi: 10.1007/s00234-015-1582-9. Epub 2015 Sep 12.
9
Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.动态对比增强T1磁共振成像灌注可区分胶质母细胞瘤假性进展与复发。
J Neurooncol. 2015 Oct;125(1):183-90. doi: 10.1007/s11060-015-1893-z. Epub 2015 Aug 15.
10
Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas.弥散敏感对比增强磁共振成像(DSC-MRI)与动态对比增强磁共振成像(DCE-MRI)在星形细胞瘤术前分级中诊断准确性的比较
AJNR Am J Neuroradiol. 2015 Nov;36(11):2017-22. doi: 10.3174/ajnr.A4398. Epub 2015 Jul 30.